InvestSMART

Acusensus Limited (ASX: ACE) - Announcements

Current share price for ACE : $1.085 0.035 (3.13%)+

ASX company news and announcements for Acusensus Limited (ACE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acusensus Limited (ACE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acusensus Limited (ACE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acusensus Limited (ACE)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$185 Acusensus FY24 Results Webinar 29 Jul 2024 8:21AM $0.550 $1.085 risen by 97.27%
$185 Q4 FY24 Quarterly Activities Report and Appendix 4C 24 Jul 2024 8:14AM $0.570 $1.085 risen by 90.35%
$185 Notification of cessation of securities - ACE 2 Jul 2024 5:53PM n/a $1.085 n/a
$185 Appendix 3Y - Change of Director's Interest Notice 20 Jun 2024 8:20AM $0.600 $1.085 risen by 80.83%
$185 Appendix 3Y - Change of Director's Interest Notice 12 Jun 2024 8:35AM $0.550 $1.085 risen by 97.27%
$185 Application for quotation of securities - ACE 31 May 2024 5:56PM $0.615 $1.085 risen by 76.42%
$185 Appendix 3Y - Change of Director's Interest Notices 31 May 2024 5:56PM $0.615 $1.085 risen by 76.42%
$185 Wilsons Conference Presentation and Contracts Update 23 May 2024 8:00AM $0.630 $1.085 risen by 72.22%
$185 Update to Q3 FY24 Quarterly Activities Report 1 May 2024 6:50PM $0.690 $1.085 risen by 57.25%
$185 Q3 FY24 Quarterly Activities Report and Appendix 4C 29 Apr 2024 8:21AM $0.700 $1.085 risen by 55%
$185 Q3 FY24 Quarterly Results Webinar 24 Apr 2024 9:53AM $0.685 $1.085 risen by 58.39%
$185 Acusensus Files Proceedings for Patent Infringement 18 Apr 2024 5:21PM $0.690 $1.085 risen by 57.25%
$185 Notification of cessation of securities - ACE 11 Apr 2024 6:15PM $0.610 $1.085 risen by 77.87%
$185 United States Work Zone Speed Tender Update 4 Mar 2024 8:18AM $0.780 $1.085 risen by 39.10%
$185 Western Europe Tender Outcome 27 Feb 2024 8:09AM $1.140 $1.085 fallen by 4.82%
$185 Acusensus 1H FY24 Investor Presentation 26 Feb 2024 8:02AM $1.090 $1.085 fallen by 0.46%
$185 Acusensus 1H FY24 Results Release 26 Feb 2024 8:01AM $1.090 $1.085 fallen by 0.46%
$185 Acusensus Appendix 4D and Half-Year Financial Report 26 Feb 2024 8:01AM $1.090 $1.085 fallen by 0.46%
$185 Acusensus Preferred Vendor in US Speed Contract Tender 12 Feb 2024 8:16AM $0.930 $1.085 risen by 16.67%
$185 Acusensus H1 FY24 Results Webinar 30 Jan 2024 8:21AM $0.850 $1.085 risen by 27.65%
$185 Q2 FY24 Quarterly Activities Report and Appendix 4C 29 Jan 2024 8:25AM $0.850 $1.085 risen by 27.65%
$185 New mobile phone detection contract in South Australia 8 Jan 2024 8:26AM $0.845 $1.085 risen by 28.40%
$185 Notification of cessation of securities - ACE 2 Jan 2024 7:35PM $0.800 $1.085 risen by 35.63%
$185 Ceasing to be a substantial holder 27 Dec 2023 8:21AM $0.795 $1.085 risen by 36.48%
$185 Notification regarding unquoted securities - ACE 15 Dec 2023 5:39PM $0.790 $1.085 risen by 37.34%

151 - 175 of 365 results

Page 7 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.